An ongoing phase 1/1b trial investigating novel treatment regimens with mosunetuzumab in relapsed/refractory B-cell non-Hodgkin lymphoma Meeting Abstract
| Authors: | Kim, W. S.; Assouline, S.; Bartlett, N. L.; Bosch, F.; Budde, L. E.; Cheah, C.; Gregory, G. P.; Hong, J.; Ku, M.; Marlton, P.; Matasar, M.; Nastoupil, L.; Panizo, C.; Sehn, L. H.; Tzachanis, D.; Chu, W.; Hernandez, M. G.; Kwan, A.; Li, C. C.; Sison, I. |
| Abstract Title: | An ongoing phase 1/1b trial investigating novel treatment regimens with mosunetuzumab in relapsed/refractory B-cell non-Hodgkin lymphoma |
| Meeting Title: | 15th International Conference on Malignant Lymphoma |
| Journal Title: | Hematological Oncology |
| Volume: | 37 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2019 Jun 18-22 |
| Meeting Location: | Lugano, Switzerland |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2019-06-01 |
| Start Page: | 567 |
| End Page: | 568 |
| Language: | English |
| ACCESSION: | 137029171 |
| DOI: | 10.1002/hon.15_2632 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cin20 |
| PUBMED: | 31187525 |
| DOI/URL: | |
| Notes: | Meeting abstract: OT22 -- Accession Number: 137029171 -- Entry Date: In Process -- Revision Date: 20190620 -- Publication Type: Article -- Supplement Title: Jun2019 Supplement S2 -- Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 8307268. -- Source: cin20 |
